Recruiting
Investigational
Evaluation of Choline Chloride for Intestinal Failure Patients Receiving Long-Term Parenteral Support
Investigational
- Substances:–
Countries:
Poland
Poland- Participants:0–17 years · 18–64 years · 65+ years
Find therapies in clinical trials near you – page 46
- recruiting
- 3 982
- countries
- 28
- conditions
- 2 106
3 982 trials recruiting28 European countries2 106 conditions coveredUpdated today
2 729 trials match your criteria
Recruiting
Follicular lymphoma
RecruitingStudy Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
Registered drugNo placebo
Study Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
Registered drugNo placebo
- Disease:Follicular lymphoma
- Substances:CyclophosphamideGolcadomide+8
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Cyclophosphamide
Recruiting
Phenylketonuria
RecruitingStudy of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin
Registered drugNo placebo
Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin
Registered drugNo placebo
- Disease:Phenylketonuria
- Substances:Sepiapterin
Countries:Poland
Poland- Participants:0–17 years
- Substances:Sepiapterin
Recruiting
Dermatitis atopic
RecruitingEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
Investigational
Effectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
Investigational
- Disease:Dermatitis atopic
- Substances:Abrocitinib
Countries:Poland
Poland- Participants:0–17 years
- Substances:Abrocitinib
Recruiting
Malignant melanoma
RecruitingVusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments
Registered drugNo placebo
Vusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments
Registered drugNo placebo
- Disease:Malignant melanoma
- Substances:Dacarbazine CitrateNivolumab+5
Countries:Poland
Poland- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Dacarbazine Citrate
Recruiting
Endometrial cancer
RecruitingStudy of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients
Registered drugNo placebo
Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients
Registered drugNo placebo
- Disease:Endometrial cancer
- Substances:CarboplatinDocetaxel+6
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Carboplatin
Recruiting
Psoriatic arthropathy
RecruitingStudy on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
InvestigationalNo placebo
Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
InvestigationalNo placebo
- Disease:Psoriatic arthropathy
- Substances:LutikizumabRisankizumab
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Lutikizumab
Recruiting
Endometrial cancer
RecruitingStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer
Registered drugNo placebo
Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer
Registered drugNo placebo
- Disease:Endometrial cancer
- Substances:CarboplatinCodeine Phosphate+7
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Carboplatin
Recruiting
Primary biliary cholangitis
RecruitingStudy of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
Investigational
Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
Investigational
- Disease:Primary biliary cholangitis
- Substances:Seladelpar
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Seladelpar
Recruiting
Immune thrombocytopenia
RecruitingStudy on the Safety and Effectiveness of Pirtobrutinib for Adults with Immune Thrombocytopenia
Investigational
Study on the Safety and Effectiveness of Pirtobrutinib for Adults with Immune Thrombocytopenia
Investigational
- Disease:Immune thrombocytopenia
- Substances:Pirtobrutinib
Countries:Poland
Poland- Participants:18–64 years
- Substances:Pirtobrutinib
Recruiting
Ischaemic stroke
RecruitingStudy on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke
Investigational
Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke
Investigational
- Disease:Ischaemic stroke
- Substances:JX10
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:JX10
Recruiting
Investigational
Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists
Investigational
- Substances:Finerenone
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Finerenone